Did you know?

Palatin Technologies, Inc. is a biopharmaceutical company developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCr) system. The Companyâ s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need.Stephen A. Slusher is Chief Legal Officer and Assistant Secretary of Palatin Technologies, Inc. Previously he was a partner in a boutique intellectual property law firm in Albuquerque, New Mexico, Peacock Law PC, where he remains of counsel. Earlier in his career he was involved in the creation of several biotechnology companies. He is a registered patent …Dec 1, 2023 · View Palatin Technologies, Inc PTN investment & stock information. Get the latest Palatin Technologies, Inc PTN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system ...The reverse stock split reduced the number of shares of Palatin’s common stock outstanding from approximately 231,774,000 shares to approximately 9,271,000 shares but did not change the authorized number of shares of Common Stock, which remain at 300,000,000 shares of Common Stock. Fiscal First Quarter Ended September 30, 2022 Financial ResultsNov 30, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Palatin Technologies stock is Buy based on the current 1 buy rating for PTN. The average twelve-month price prediction for Palatin Technologies is $70.00 with a high price target of $70.00 and a low price target of $70.00. Learn more on PTN's analyst rating ... That new price target for PTN stock represents massive growth potential for the company. The $5 price prediction is a roughly 1,371% upside for the stock compared to its closing price on Tuesday ...Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies. Stock …Dec 7, 2021 · Palatin Technologies Stock Forecast 11-20-2023. Forecast target price for 11-20-2023: $ 2.05. Positive dynamics for Palatin Technologies shares will prevail with possible volatility of 5.518%. Pessimistic target level: 2.00. Optimistic target level: 2.12. Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, ...According to 1 stock analyst, the 12-month stock price forecast for PTN stock stock is $70, which predicts an increase of 3,471.43%. On average, analysts rate ...Nov 29, 2023 · Palatin Technologies' stock was trading at $3.87 at the start of the year. Since then, PTN stock has decreased by 51.9% and is now trading at $1.86. View the best growth stocks for 2023 here. Information on stock, financials, earnings, subsidiaries, investors, and executives for Palatin Technologies. Use the PitchBook Platform to explore the full ...The Palatin Technologies, Inc. 2005 Stock Plan, as amended (the “Prior Plan”) terminated in its entirety effective on the Approval Date; provided that all outstanding awards under the Prior Plan as of the Approval Date remain outstanding and shall be administered and settled in accordance with the provisions of the Prior Plan. ...Palantir Technologies ( PLTR 1.06%) has been on a tear Facebook, a stock hedge funds have loved dearly, lost nearly 40% of it Palatin Technologies' CEO is Carl Spana, appointed in Jun 2000, has a tenure of 23.42 years. total yearly compensation is $1.30M, comprised of 53.7% salary and 46.3% bonuses, including company stock and options. directly owns 0.71% of the company’s shares, worth $194.97K. The average tenure of the management team and the board of directors is ... Palatin Technologies (PTN) shares are up over 30% after Get a real-time Palatin Technologies, Inc. (PTN) stock price quote with breaking news, financials, statistics, charts and more.Palatin Technologies Inc stock performance at a glance. Check Palatin Technologies Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Palatin Technologies, Inc. is a biopharmaceutical company, which en

The latest closing stock price for Palatin Technologies as of December 01, 2023 is 2.22. The all-time high Palatin Technologies stock closing price was 2407.50 on October 17, …Palantir Technologies Inc. PLTR shares are trading lower Monday amid a broader sell-off in the tech sector. Here's a look at what to know: . What To Know: …Ives’s bullish view of Palantir Technologies is for the long term. The analyst claims Palantir has “built an AI fortress that is unmatched and poised to be a major player in this AI Revolution ...Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system ...

Nov 24, 2023 · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... Palatin Technologies, Inc is a development-stage medical technology company involved in developing and commercializing products and technologies for diagnostic imaging, cancer therapy and ethical ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Palatin Technologies, Inc. is a biopharmaceutical. Possible cause: Sep 16, 2023 · Get Palatin Technologies Inc (PTN.A) real-time stock q.